Valuation: Yuhan Corporation

Market Cap 5,518B 3.8B 3.34B 3.12B 2.86B 5.36B 364B 5.49B 36.99B 14.46B 180B 14.28B 13.97B 623B P/E 2026 *
40.6x
P/E 2027 * 26.6x
Enterprise Value 5.43B 3.74M 3.29M 3.07M 2.82M 5.27M 358M 5.4M 36.4M 14.23M 177M 14.05M 13.74M 613M EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.07x
Free-Float
64.28%
Yield 2026 *
0.75%
Yield 2027 * 0.76%
1 day+5.26%
1 week+5.41%
Current month+5.41%
1 month+0.27%
3 months-20.60%
6 months-32.85%
Current year-34.16%
1 week 68,500
Extreme 68500
77,100
1 month 66,200
Extreme 66200
77,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+5.26%+5.41%-38.54%+12.12% 3.61B
-1.11%-1.08%+57.88%+21.02% 322B
-1.55%+2.59%+28.35%-10.61% 71.8B
-0.94%+2.26%+37.60%+92.43% 9.88B
-1.96%+0.88%+2.59%-1.56% 8.64B
+2.65%+1.04%-23.09%-5.02% 4.08B
-3.86%-8.12%-14.18%-2.26% 3.61B
-1.81%-2.87%+36.58%+49.35% 2.7B
-0.68%+4.21%-7.83%-5.33% 2.24B
-5.33%-12.77%-32.37%+13.32% 1.79B
Average -0.94%+1.03%+4.70%+16.35% 43.03B
Weighted average by Cap. -1.16%+4.42%+48.34%+16.42%

Financials

2026 *2027 *
Net sales 2,333B 1.61B 1.41B 1.32B 1.21B 2.27B 154B 2.32B 15.64B 6.12B 76.21B 6.04B 5.91B 263B 2,586B 1.78B 1.57B 1.46B 1.34B 2.51B 171B 2.57B 17.33B 6.78B 84.48B 6.69B 6.55B 292B
Net income 143B 98.56M 86.6M 80.84M 74.19M 139M 9.44B 142M 959M 375M 4.67B 370M 362M 16.15B 212B 146M 129M 120M 110M 206M 14.02B 211M 1.42B 557M 6.94B 549M 538M 23.98B
Net Debt -88.37B -60.91M -53.52M -49.96M -45.85M -85.82M -5.83B -87.94M -592M -232M -2.89B -229M -224M -9.98B -166B -115M -101M -94M -86.27M -161M -10.98B -165M -1.11B -436M -5.43B -430M -421M -18.78B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-07-29 74,000.00 +5.26% 404,645
26-07-29 ₩70,300.00 -0.57% 464,533
26-07-28 ₩70,700.00 -1.81% 229,612
26-07-27 ₩72,000.00 -3.87% 202,403
26-07-24 ₩74,900.00 +4.90% 454,629
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
70,300.00KRW
Average target price
127,555.56KRW
Spread / Average Target
+81.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock